FUSION PHARMACEUTICALS INC.
associated with 3 other trademarks
Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payl...

Words that describe this trademark:

clinical research  drug discovery  material used  used drug  discovery pharmaceutical  pharmaceutical development  bifunctional  research  development  chelate 

Serial Number:

90667636

Mark:

FUSION PHARMACEUTICALS INC.

Status:

Registered

Status Date:

07-25-2023

Filing Date:

Registration Number:

7122418

Registration Date:

07-25-2023

Goods and Services:

Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells, including but not limited to cancer cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use

Mark Description:

The mark consists of the stylized word "FUSION" in black letters with an image of an atomic model in gray and orange and the stylized words "PHARMACEUTICALS INC". in black letters below it.

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

05-31-2022

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

N/A

Business Name:

PIERCE ATWOOD LLP

Correspondent Name:

Recent Trademark filings by this company